Condition: Osteoarthritis of Hip · Sponsor: Hip Innovation Technology
To evaluate effectiveness and safety of HHRS in subjects undergoing total hip arthroplasty (THA). Effectiveness will be evaluated using patient-reported, clinical, radiologic, and radiostereometric outcomes. Safety will be evaluated through the collection of device-related and unanticipated device-related adverse events.
This description comes directly from the study's public registry record.
Linda Braddon, PhD · 770-837-2681 · LGB@SecureBME.com
Thomas Turgeon, MD · 204-926-1218 · tturgeon@cjrg.ca
Always discuss trial participation with your own doctor first.
| Orthopaedic Innovation Centre | Winnipeg, Manitoba, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02836262